DrugPatentWatch Database Preview
Drugs in Development Information for Voclosporin
Development status for investigational drug Voclosporin: Sponsors, patents, clinical trial progress
Voclosporin is an investigational drug.
There have been 15 clinical trials for Voclosporin.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2011.
The most common disease conditions in clinical trials are Nephritis, Lupus Nephritis, and Psoriasis. The leading clinical trial sponsors are Aurinia Pharmaceuticals Inc., Lux Biosciences, Inc., and Weill Medical College of Cornell University.
Summary for Voclosporin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 6 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2011-02-01) |
| Vendors | 7 |
Recent Clinical Trials for Voclosporin
| Title | Sponsor | Phase |
|---|---|---|
| Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease | Aurinia Pharmaceuticals Inc. | Phase 2 |
| Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis | Aurinia Pharmaceuticals Inc. | Phase 2 |
| Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin | Aurinia Pharmaceuticals Inc. | Phase 3 |
Clinical Trial Summary for Voclosporin
Top disease conditions for Voclosporin
Top clinical trial sponsors for Voclosporin
US Patents for Voclosporin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
